Investor Presentaiton
Q3 2023 Financial Highlights (continued)
Total Revenue
($ in millions)
Short Distance
($ in millions)
MediMobility Organ
Transport
($ in millions)
+56%
+49%
$71.4
$20.4
$45.7
Q3'22
Q3'23
Q3'22
$30.4
Q3'23
+65%
$33.4
$20.2
Q3'22
Q3'23
Total revenue expansion
propelled by organic growth in
MediMobility Organ Transport,
complemented by a combination
of acquisitions and organic growth
in Short Distance
•
Growth driven by our acquisition
of Blade Europe and strong
growth in our Blade Airport
service and other Short Distance
business lines
•
Growth driven by the addition of
new transplant center customers,
continued growth with existing
customers, and strong end market
demand
BLADE
Jet/Other
($ in millions)
+49%
$7.6
$5.1
Q3'22
Q3'23
•
Reflects increase in jet charter
volume
23
23View entire presentation